Carlyle Group invested in Resonetics, which manufactures medical devices, in a deal valuing the company at $2.25 billion. Carlyle joins existing investor GTCR. Carlyle’s experience investing in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback